Palliative Management of Malignant Rectosigmoidal Obstruction. Colostomy vs. Endoscopic Stenting. A Randomized Prospective Trial
Background: Colostomy was the palliative treatment of choice in patients with malignant unresectable rectosigmoid obstruction. Palliative endoscopic treatment of malignant rectosigmoid obstruction by endoluminal self-expanding metallic stents is nowadays a well-established procedure. Patients and Me...
Gespeichert in:
Veröffentlicht in: | Anticancer research 2004-01, Vol.24 (1), p.265-268 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Background: Colostomy was the palliative treatment of choice in patients with malignant unresectable rectosigmoid obstruction.
Palliative endoscopic treatment of malignant rectosigmoid obstruction by endoluminal self-expanding metallic stents is nowadays
a well-established procedure. Patients and Methods: Twenty-two patients, referred for treatment with diagnosis of malignant
obstruction of the rectosigmoid region presenting an advanced unresectable stage, were enrolled. Patients were randomily assigned
into two treatment groups (endoscopic stenting vs colostomy) according to random-number tables. The length of procedure, morbidity
and mortality rate, canalization of the gastrointestinal tract, restoration of oral intake and hospital stay were assessed.
Results: Endoscopic group: The median length of procedure was 36 minutes. No death was observed. None of the patients reported
complications. All patients resumed bowel function within 24 hours. The restoration of oral intake was achieved one day after
stent placement. The median hospital stay was 2.6 days. Colostomy group: The median length of the operation was 75.4 minutes.
No mortality was reported. In 1 patient (9.1%) stoma prolapse was observed 3 days after the operation. Canalization of the
gastrointestinal tract was restored when colostomy was opened (on postoperative day 3). All patients were able to resume oral
feedings on postoperative day 3. The median hospital stay was 8.1 days. Conclusion: There were no statistically significant
differences between the 2 groups concerning morbidity and mortality. Endoscopic stenting was significantly more effective
concerning operative time, restoration of bowel function and oral intake and median hospitalization. Our results would suggest
that endoscopically placed metal stents offer an effective alternative to surgical palliation in patients suffering from unresectable
malignant rectosigmoid obstruction. |
---|---|
ISSN: | 0250-7005 1791-7530 |